- Home
- MX vs HUMA Comparison
MX vs HUMA Comparison
Compare MX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | HUMA |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 165.7M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MX | HUMA |
|---|---|---|
| Price | $2.73 | $0.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $5.75 | ★ $6.19 |
| AVG Volume (30 Days) | 307.6K | ★ 5.0M |
| Earning Date | 04-28-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.06 | ★ 79.37 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $178,860,000.00 | $2,038,000.00 |
| Revenue This Year | $8.55 | $444.16 |
| Revenue Next Year | $6.37 | $248.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $0.53 |
| 52 Week High | $9.86 | $2.55 |
Technical Indicators
Market Signals| Indicator | MX | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 30.36 | 44.13 |
| Support Level | $2.59 | $0.54 |
| Resistance Level | $2.81 | $0.75 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 7.84 | 37.55 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.